Seres Therapeutics, Inc. (MCRB)

NASDAQ: MCRB · Real-Time Price · USD

5.54

+0.36 (6.95%)

At close: Sep 2, 2026, 4:00 PM EDT

5.54

0.00 (0.00%)

After-hours: Sep 2, 2026, 7:30 PM EDT

Seres Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	15.59	45.77	30.79	127.97	163.03	180
Short-Term Investments	-	-	-	-	18.31	110.7
Cash & Short-Term Investments	15.59	45.77	30.79	127.97	181.34	290.71
Cash Growth	-65.64%	48.63%	-75.94%	-29.43%	-37.62%	14.62%
Receivables	25.27	0.52	4.75	-	-	-
Prepaid Expenses	1.48	3.09	3.13	8.05	13.42	12.92
Other Current Assets	-	-	-	39.4	-	-
Total Current Assets	42.35	49.38	38.67	175.41	194.76	303.63
Property, Plant & Equipment	56.97	80.12	92.44	108.03	133.97	36.15
Long-Term Investments	-	-	-	-	-	0.5
Other Long-Term Assets	2.27	8.7	8.7	75.16	20.05	14.59
Total Assets	101.59	138.19	139.81	358.6	348.78	354.86

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	1.19	1.68	4.08	3.64	17.44	13.74
Accrued Expenses	3.74	3.97	10.72	22.51	25.07	24
Current Portion of Long-Term Debt	-	-	-	-	0.46	-
Current Portion of Leases	11.83	10.39	8.67	5.59	3.6	6.61
Current Unearned Revenue	-	-	-	-	4.26	16.82
Other Current Liabilities	3.28	3.28	17.75	66.92	34.77	21.1
Total Current Liabilities	20.03	19.32	41.22	98.66	85.6	82.26
Long-Term Debt	-	-	-	101.54	50.59	24.64
Long-Term Leases	44.82	72.58	82.97	91.65	107.94	17.96
Long-Term Unearned Revenue	-	-	-	-	92.43	87
Other Long-Term Liabilities	2.21	2.08	1.84	111.6	1.44	11.5
Total Liabilities	67.05	93.98	126.03	403.46	338	223.35

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.01	0.01	0.01	0.14	0.13	0.09
Additional Paid-In Capital	1,022	1,017	991.87	933.24	875.18	745.83
Retained Earnings	-987.74	-972.4	-978.1	-978.24	-864.51	-614.35
Comprehensive Income & Other	-	-	-	-	-0.01	-0.06
Shareholders' Equity	34.53	44.22	13.78	-44.86	10.78	131.51
Total Liabilities & Equity	101.59	138.19	139.81	358.6	348.78	354.86

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	56.64	82.97	91.64	198.78	162.59	49.21
Net Cash (Debt)	-41.05	-37.2	-60.85	-70.82	18.75	241.5
Net Cash Growth	-	-	-	-	-92.23%	13.46%
Net Cash Per Share	-4.40	-4.19	-7.83	-11.06	3.47	52.67
Filing Date Shares Outstanding	9.94	9.59	8.72	7.55	6.3	4.6
Total Common Shares Outstanding	9.83	9.56	8.65	6.75	6.26	4.59
Working Capital	22.32	30.05	-2.55	76.75	109.17	221.37
Book Value Per Share	3.51	4.63	1.59	-6.64	1.72	28.62
Tangible Book Value	34.53	44.22	13.78	-44.86	10.78	131.51
Tangible Book Value Per Share	3.51	4.63	1.59	-6.64	1.72	28.62
Machinery	29.62	32.43	32.92	33.09	31.58	23.61
Construction In Progress	0.86	0.86	0.86	1.11	3.97	1.67
Leasehold Improvements	30.61	30.95	30.95	32.49	32.47	32.93

SEC Filings: 10-K · 10-Q